Top Machine Learning Companies in San Diego, CA (66)

Strong Revenue Growth: Company updates describe orders and revenue doubling year over year in FY2026, with independent estimates showing substantial growth through 2024. Additional reporting notes a projection of more than 80% revenue growth for 2026.

Investor Backing & Capital Strength: A $2 billion financing package in March 2026 at a $12.7 billion post-money valuation is cited, including a large Series G and preferred equity. The capital was linked to expansion initiatives and the planned acquisition of Aechelon Technology.

Market Expansion: New defense wins and international deployments are described, including a U.S. Air Force production contract, Coast Guard and Navy programs, and activity across Europe and the Asia-Pacific. Company communications also highlight wider adoption of Hivemind and expansion of V-BAT operations.

Market Expansion: Facilities, workforce, and a seven-location U.S. footprint have scaled markedly since 2010 as operations extended from airborne processing into cyber, undersea, space, land, and maritime systems. Current hiring across engineering and program roles reinforces an expanding presence in multiple hubs.

Innovation-Driven Growth: Capability breadth now spans six areas—AI/analytics, autonomy, hardware systems, cyber effects, sensing and spectrum, and adaptive mission engineering—with technology reuse across programs. Documented SBIR activity and awards from DARPA and the military services indicate momentum anchored in advanced R&D.

Diversified Customer Base: Federal contracting activity spans DARPA and the Air Force, Navy, and Army, demonstrating access to multiple defense customers. This multi-agency footprint reduces dependence on any single sponsor within the government sector.

Strong Revenue Growth: Revenue expanded on an annual basis and continued to rise into 2026, while software annual contract value increased, indicating underlying demand. Drug discovery contributions and growing software contract activity supported the top line despite timing effects in reported software revenue.

Strategic Partnerships: Collaborations with major pharmaceutical companies and acquisition-related milestones added material revenue and visibility. These relationships complement the software business and reinforce commercial traction across discovery programs.

Investor Backing & Capital Strength: A sizable cash and securities position at mid-2026 provides runway to fund operations and product transitions. Management’s multi‑year profitability targets suggest the balance sheet can support continued investment while losses narrow.

Strong Revenue Growth: Company-reported figures indicate scale to roughly $80 million in 2024 annual contract value and recognition on the Inc. 5000 list for rapid multi-year expansion. Government contract obligations under a production vehicle and continued awards further reflect meaningful commercial momentum, even as contract ceilings are not revenue.

Profitability: The business is described as having achieved three consecutive profitable years while expanding contract value. This points to growth supported by operating discipline rather than reliance solely on external financing.

Market Expansion: A transition from a DIU prototype to a production-scale agreement and reported deployment across all U.S. military branches and combatant commands indicate widening reach within the defense market. Partnerships and authorizations announced in 2026 are positioned to extend access across combatant commands and federal agencies.

Profitability: Operating earnings and margins improved notably in 2026, with Q3 operating earnings up sharply year over year and the operating margin rising to 5.6%. Feedback suggests earnings resilience is being supported by operational changes and a shifting business mix.

Strong Revenue Growth: Reported annual revenue expanded from $226.6B in 2023 to $270.6B in 2025, including roughly 12% growth in 2024 and 7% in 2025. This establishes a robust multi‑year revenue trajectory even as recent growth rates have moderated.

Cost & Operational Efficiency: Cost controls and operational improvements are described as lifting earnings despite lower revenue in 2026. Optum Health’s operating earnings rose from $41M to $735M year over year while serving fewer value‑based patients, indicating stronger execution.

Product Line Growth: Newer and acquired medicines grew 18% operationally in Q2 2026, while revenue excluding Comirnaty and Paxlovid rose 5% operationally in the same period. Excluding COVID products, 2025 revenue also increased 6% operationally, supported by growth in products such as Eliquis and Padcev.

Cost & Operational Efficiency: Management is pursuing additional savings to improve operational efficiency and support profitability. These cost-control efforts are intended to help the business transition away from pandemic-driven sales while supporting margins.

Innovation-Driven Growth: Investment in future growth includes $10.4 billion in internal R&D during 2025 and ongoing development in oncology and obesity. A broad pipeline and recent acquisitions are intended to offset declining COVID-19 sales and patent expirations if programs succeed.

Strong Revenue Growth: Recent quarters show robust top-line expansion and recurring revenue momentum, with results exceeding expectations in multiple updates. Feedback suggests ARR has increased sequentially and subscriptions now account for a larger mix, aiding gross margin improvement.

Future-Ready Strategy: The transition to a unified, cloud-first, subscription model—augmented by AI offerings and targeted acquisitions—indicates a focus on scalable, higher-margin growth. Feedback suggests expansion into adjacent markets and enhanced data capabilities is designed to support durability and cross-sell.

Strategic Partnerships: Large enterprise deployments and agreements with national brands, plus integrations with ecosystem partners, are broadening reach and validating execution at scale. Feedback suggests these relationships create pathways for upsell across POS, loyalty, ordering, and payments.

Strong Revenue Growth: External accolades indicate outsized multi‑year revenue expansion, including being named Adweek’s 2023 #1 Fastest Growing Agency and ranking No. 58 on the 2024 Inc. 5000. Leadership communications reference continued momentum into 2026, reinforcing a trajectory of ongoing top‑line gains.

Innovation-Driven Growth: Capability buildouts in AI and automation—such as launching Catapult and acquiring BotsCrew—align offerings to rising client demand for AI agents and automation. These investments broaden the firm’s digital transformation remit and strengthen its growth platform.

Market Expansion: Enterprise‑level remits and federal wins, including a direct AOR role with the U.S. Air Force Rapid Sustainment Office, show reach beyond project work. Multiple U.S. offices, a rising LinkedIn headcount band, and a larger Cincinnati footprint point to a widening geographic presence.

Market Expansion: Expansion into ten U.S. cities, new depots in Dallas and Phoenix, and a Scottsdale command center indicate a broadening operational footprint. Public rides in Las Vegas and San Francisco with over one million autonomous miles signal readiness to scale into paid service pending approvals.

Strategic Partnerships: A multi-year integration with Uber starting in Las Vegas in 2026 (and Los Angeles in 2027) expands distribution and rider access. Venue tie-ups in Las Vegas and supplier arrangements support commercialization as the fleet scales.

Investor Backing & Capital Strength: Amazon ownership and a new Bay Area manufacturing facility reflect strong capital support to ramp production and operations. Ongoing hiring and production plans for 2026 underscore resourcing for the transition to paid service.

Strong Market Position & Advantage: Altera is widely characterized as one of the two dominant FPGA vendors, with notable strength in high‑end Agilex devices and a broad, refreshed portfolio. This standing is reinforced by its re‑emergence as the largest independent pure‑play FPGA company and leadership’s intent to take share from AMD/Xilinx.

Product Line Growth: Since separation, the company has expanded Agilex families (e.g., Agilex 5/3/7) and advanced its Quartus/FPGA AI tooling to address edge through data‑center use cases. These launches and updates indicate sustained investment aimed at enlarging addressable markets and improving time‑to‑market.

Investor Backing & Capital Strength: The 2025 majority investment by Silver Lake, with Intel retaining a significant stake, establishes a well‑capitalized, standalone structure. This ownership setup is positioned to accelerate roadmap execution and innovation across high‑growth segments like AI/data centers and 5G.

Strong Market Position & Advantage: Independent industry tracking places Oura as the dominant smart‑ring vendor, maintaining leadership even as new entrants scale. Shipment growth for the category accelerated while Oura remained the leader.

Strong Revenue Growth: Company and third‑party reports indicate revenue roughly doubled in 2024 with guidance to surpass prior levels in 2025, alongside a sharp acceleration in unit sales. Recent disclosures cite more than half of cumulative sales occurring in the prior year.

Investor Backing & Capital Strength: Late‑2025 fundraising at a significantly higher valuation and substantial capital raised point to strong investor confidence. Added partnerships and ecosystem integrations, including glucose insights collaborations, reinforce access to resources.

Strong Market Position & Advantage: Abalta is positioned as a recognized niche leader in smartphone-projection infotainment for the aftermarket, with WebLink pre-integrated across major head-unit brands and cited deployment in millions of vehicles. This installed base and long tenure indicate defensible reach within its specific segment even if it is not the default platform in mainstream OEM infotainment.

Strategic Partnerships: Partnership depth is evidenced by WebLink being referenced on Pioneer and other head-unit makers’ product/support pages and by Abalta’s co-hosted event presence with Zenrin at CES 2026. Zenrin ownership and the consolidation of Zenrin USA into Abalta also reinforce strategic alignment and routes to market.

Product Line Growth: The portfolio has expanded beyond the original WebLink offering to include WebLink 4.0, WebLink for Motorcycles, FusionSync, and cloud mobility services highlighted in early 2026. This broadening suggests continued investment in adjacent platforms and delivery capabilities.